Click image to enlarge
The
V-PLEX platform offers analytically validated singleplex and multiplex assay kits. Developed under rigorous design control, V-PLEX kits provide accurate and reproducible results with consistency from lot to lot. The V-PLEX Plus Aβ Peptide Panel 1 (6E10) Kit includes three biomarkers that are associated with neurodegenerative diseases (AD) (Table 1). The assays can be used for quantitative measurements in the sample types listed in the “Specifications” tab below and offer detection limits (LLODs and LLOQs) in the sub- to low pg/mL range.
V-PLEX Plus kits include controls, wash buffer, and plate seals.
| Analyte | LLOD | LLOQ | ULOQ | Dynamic Range | Unit | | Aβ38 (6E10) | 16.7 | 60.0 | 8,480 | 16.7 - 8,480 | pg/mL |
| Aβ40 (6E10) | 9.97 | 50.0 | 7,000 | 9.97 - 7,000 | pg/mL |
| Aβ42 (6E10) | 0.368 | 3.13 | 1,270 | 0.368 - 1,270 | pg/mL |
-
-
Specifications
-
Kit Contents
-
Documentation
-
References
|
Application(s)
|
|
Alzheimer’s Disease
,
Neurobiology/Neurodegeneration
|
|
|
Analyte(s)
|
|
Aβ38 (6E10), Aβ40 (6E10), Aβ42 (6E10)
|
|
|
Species
|
|
Human
|
|
|
Instrument(s)
|
|
SECTOR Imager 2400
,
MESO SECTOR S 600MM
,
SECTOR Imager 6000
,
MESO QuickPlex SQ 120MM
,
MESO QuickPlex SQ 120
,
MESO SECTOR S 600
|
|
|
Plate Type
|
|
96-well
|
|
|
Sample Type
|
|
Cell Culture Supernatant, Tissue Homogenate, CSF
|
|
|
Usage Statement
|
|
For Research Use Only. Not for use in diagnostic procedures.
|
|
|
Storage Statement(s)
|
|
Please refer to the product insert for the storage conditions of individual kit components.
|
|
|
Storage Condition
|
|
Multi-Component
|
|
|
Schedule B Code
|
|
3822.19.0000
|
|
|
Product Description
|
Storage
|
Quantity per Kit
|
|
Neurodegeneration Control 1
|
≤-70 °C
|
1 vial
(1 vial)
|
|
|
|
Neurodegeneration Control 2
|
≤-70 °C
|
1 vial
(1 vial)
|
|
|
|
Neurodegeneration Control 3
|
≤-70 °C
|
1 vial
(1 vial)
|
|
|
|
|
≤-70 °C
|
1 vial
(30 μL)
|
|
|
|
|
≤-70 °C
|
1 vial
(30 μL)
|
|
|
|
|
≤-70 °C
|
1 vial
(30 μL)
|
|
|
|
|
2-8 °C
|
1 vial
(75 μL)
|
|
|
|
Aβ Peptide Panel 1 Plate
|
2-8 °C
|
1 each
(1 each)
|
|
|
|
Diluent Assembly 9 (includes Diluent 35 – 30 mL, Diluent 100 – 50 mL)
|
2-8 °C
|
1 each
(1 each)
|
|
|
|
|
RT
|
1 bottle
(100 mL)
|
|
|
|
|
RT
|
1 bottle
(50 mL)
|
|
|
|
|
2-8 °C
|
1 vial
(40 μL)
|
|
|
|
Product Description
|
Storage
|
Quantity per Kit
|
|
Neurodegeneration Control 1
|
≤-70 °C
|
5 vial
(1 vial)
|
|
|
|
Neurodegeneration Control 2
|
≤-70 °C
|
5 vial
(1 vial)
|
|
|
|
Neurodegeneration Control 3
|
≤-70 °C
|
5 vial
(1 vial)
|
|
|
|
|
≤-70 °C
|
5 vial
(30 μL)
|
|
|
|
|
≤-70 °C
|
5 vial
(30 μL)
|
|
|
|
|
≤-70 °C
|
5 vial
(30 μL)
|
|
|
|
|
2-8 °C
|
1 vial
(375 μL)
|
|
|
|
Aβ Peptide Panel 1 Plate
|
2-8 °C
|
5 each
(1 each)
|
|
|
|
Diluent Assembly 10 (includes Diluent 35 – 150 mL, Diluent 100 – 50 mL)
|
2-8 °C
|
1 each
(1 each)
|
|
|
|
|
RT
|
1 bottle
(100 mL)
|
|
|
|
|
RT
|
1 bottle
(50 mL)
|
|
|
|
|
2-8 °C
|
1 vial
(200 μL)
|
|
|
|
Product Description
|
Storage
|
Quantity per Kit
|
|
Neurodegeneration Control 1
|
≤-70 °C
|
25 vial
(1 vial)
|
|
|
|
Neurodegeneration Control 2
|
≤-70 °C
|
25 vial
(1 vial)
|
|
|
|
Neurodegeneration Control 3
|
≤-70 °C
|
25 vial
(1 vial)
|
|
|
|
|
≤-70 °C
|
25 vial
(30 μL)
|
|
|
|
|
≤-70 °C
|
25 vial
(30 μL)
|
|
|
|
|
≤-70 °C
|
25 vial
(30 μL)
|
|
|
|
|
2-8 °C
|
5 vial
(375 μL)
|
|
|
|
Aβ Peptide Panel 1 Plate
|
2-8 °C
|
25 each
(1 each)
|
|
|
|
Diluent Assembly 10 (includes Diluent 35 – 150 mL, Diluent 100 – 50 mL)
|
2-8 °C
|
5 each
(1 each)
|
|
|
|
|
RT
|
5 bottle
(100 mL)
|
|
|
|
|
RT
|
5 bottle
(50 mL)
|
|
|
|
|
2-8 °C
|
5 vial
(200 μL)
|
|
|
|
Product Inserts
|
|
|
|
Certificate of analysis
|
|
View More
|
|
SDS
|
|
|
|
Title
|
Journal
|
Year
|
|
Lecanemab in Early Alzheimer's Disease
|
|
|
|
Amyloid-beta 42 adsorption following serial tube transfer.
|
|
|
|
|
|
Order Details
Catalog No
Size
Price in USD
Qty
Customer Service/Orders
Scientific/Technical Support
Instrument Support
Company Headquarters